About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.
Nogle resultater er blevet skjult, fordi de muligvis ikke er tilgængelige for dig.